Alexander Hantel

5.6k total citations · 2 hit papers
43 papers, 3.8k citations indexed

About

Alexander Hantel is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Alexander Hantel has authored 43 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Alexander Hantel's work include Colorectal Cancer Treatments and Studies (11 papers), Genetic factors in colorectal cancer (7 papers) and Nutritional Studies and Diet (7 papers). Alexander Hantel is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Genetic factors in colorectal cancer (7 papers) and Nutritional Studies and Diet (7 papers). Alexander Hantel collaborates with scholars based in United States, Canada and South Korea. Alexander Hantel's co-authors include Leonard B. Saltz, Robert J. Mayer, Donna Niedzwiecki, Jeffrey A. Meyerhardt, Donna Hollis, Renaud Whittom, Charles S. Fuchs, James P. Thomas, Catherine M. Tangen and John S. Macdonald and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Alexander Hantel

43 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Southwest Oncology Group study

1993 591 citations Catherine M. Tangen, John S. Macdonald et al. profile →
Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

2006 537 citations Jeffrey A. Meyerhardt, Donna Niedzwiecki et al. profile →

Peers

Countries citing papers authored by Alexander Hantel

Since Specialization

Citations

This map shows the geographic impact of Alexander Hantel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Hantel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Hantel more than expected).

Fields of papers citing papers by Alexander Hantel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Hantel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Hantel. The network helps show where Alexander Hantel may publish in the future.

Co-authorship network of co-authors of Alexander Hantel

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Hantel. A scholar is included among the top collaborators of Alexander Hantel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Hantel. Alexander Hantel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance) 2022 ·The Oncologist ·Seohyuk Lee, (unknown), Sui Zhang, Fang‐Shu Ou, (unknown), Donna Niedzwiecki, Leonard B. Saltz, Robert J. Mayer, Renaud Whittom, Alexander Hantel, Al B. Benson, Daniel Atienza, Hedy L. Kindler, Cary P. Gross, Melinda L. Irwin, Jeffrey A. Meyerhardt, Charles S. Fuchs	15
2	Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer 2014 ·JNCI Journal of the National Cancer Institute ·Kimmie Ng, Jeffrey A. Meyerhardt, Andrew T. Chan, Kaori Sato, Jennifer A. Chan, Donna Niedzwiecki, Leonard B. Saltz, Robert J. Mayer, Al B. Benson, Paul Schaefer, Renaud Whittom, Alexander Hantel, Richard M. Goldberg, Alan P. Venook, Shuji Ogino, Edward L. Giovannucci, Charles S. Fuchs	108
3	Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance) 2014 ·PLoS ONE ·Michael Fuchs, Kaori Sato, Donna Niedzwiecki, Xing Ye, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, Renaud Whittom, Alexander Hantel, Al B. Benson, Daniel Atienza, Michael J. Messino, Hedy L. Kindler, Alan P. Venook, Shuji Ogino, Kana Wu, Walter C. Willett, Edward L. Giovannucci, Jeffrey A. Meyerhardt	57
4	Predictive and Prognostic Analysis of PIK3CA Mutation in Stage III Colon Cancer Intergroup Trial 2013 ·JNCI Journal of the National Cancer Institute ·Shuji Ogino, (unknown), Yu Imamura, Mai Yamauchi, Nadine J. McCleary, Kimmie Ng, Donna Niedzwiecki, Leonard B. Saltz, Robert J. Mayer, Renaud Whittom, Alexander Hantel, Al B. Benson, Rex B. Mowat, Donna Spiegelman, Richard M. Goldberg, Monica M. Bertagnolli, Jeffrey A. Meyerhardt, Charles S. Fuchs	36
5	Dietary Glycemic Load and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings From CALGB 89803 2012 ·JNCI Journal of the National Cancer Institute ·Jeffrey A. Meyerhardt, Kaori Sato, Donna Niedzwiecki, (unknown), Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, Renaud Whittom, Alexander Hantel, Al B. Benson, (unknown), Alan P. Venook, Charles S. Fuchs	118
6	Predictive and Prognostic Roles of BRAF Mutation in Stage III Colon Cancer: Results from Intergroup Trial CALGB 89803 2011 ·Clinical Cancer Research ·Shuji Ogino, Kaori Shima, Jeffrey A. Meyerhardt, Nadine J. McCleary, Kimmie Ng, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, Paul Schaefer, Renaud Whittom, Alexander Hantel, Al B. Benson, Donna Spiegelman, Richard M. Goldberg, Monica M. Bertagnolli, Charles S. Fuchs	207
7	A Phase II Study of Weekly Docetaxel in Combination with Capecitabine in Advanced Gastric and Gastroesophageal Adenocarcinomas 2010 ·Oncology ·Shelly S. Lo, Alok A. Khorana, Milind Javle, Sheryl R. Simon, (unknown), (unknown), Hong Wang, Alexander Hantel, Michelle Shayne, Jimmy J. Hwang, Amy Schmotzer, Ramesh K. Ramanathan	18
8	Impact of smoking on patients with stage III colon cancer 2010 ·Cancer ·Nadine J. McCleary, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Paul Schaefer, Renaud Whittom, Alexander Hantel, Al B. Benson, Richard M. Goldberg, Jeffrey A. Meyerhardt	51
9	KRAS Mutation in Stage III Colon Cancer and Clinical Outcome Following Intergroup Trial CALGB 89803 2009 ·Clinical Cancer Research ·Shuji Ogino, Jeffrey A. Meyerhardt, Natsumi Irahara, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Robert J. Mayer, Paul Schaefer, Renaud Whittom, Alexander Hantel, Al B. Benson, Richard M. Goldberg, Monica M. Bertagnolli, Charles S. Fuchs	153
10	Association of Dietary Patterns With Cancer Recurrence and Survival in Patients With Stage III Colon Cancer 2008 ·Obstetrical & Gynecological Survey ·Jeffrey A. Meyerhardt, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Frank B. Hu, Robert J. Mayer, Heidi Nelson, Renaud Whittom, Alexander Hantel, James P. Thomas, Charles S. Fuchs	20
11	Association of Dietary Patterns With Cancer Recurrence and Survival in Patients With Stage III Colon Cancer 2007 ·JAMA ·Jeffrey A. Meyerhardt, Donna Niedzwiecki, Donna Hollis, Leonard B. Saltz, Frank B. Hu, Robert J. Mayer, Heidi Nelson, Renaud Whittom, Alexander Hantel, James P. Thomas, Charles S. Fuchs	304
12	Gastrointestinal stromal tumor: involvement in urologic patients and recent therapeutic advances 2002 ·Urology ·Bryan B. Voelzke, Kyoko Sakamoto, Alexander Hantel, Gladell P. Paner, Joseph J. Kash, W. Bedford Waters, Steven C. Campbell	16
13	Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer 2001 ·Lung Cancer ·Joseph I. Clark, (unknown), (unknown), Susan G. Fisher, Alexander Hantel, (unknown), (unknown), Kathy S. Albain	24
14	A phase II trial of piroxantrone in endometrial cancer 1996 ·Anti-Cancer Drugs ·Vinay K. Malviya, P. Y. Liu, David A. Goldberg, Alexander Hantel, Robert V. O’Toole, Ralph W. Roach, Marcel E. Conrad, David S. Alberts	4
15	A Phase II Trial of Piroxantrone in Advanced Ovarian Carcinoma after Failure of Platinum-Based Chemotherapy: Southwest Oncology Group Study 8904 1995 ·Gynecologic Oncology ·Kathy S. Albain, (unknown), Alexander Hantel, Elizabeth Poplin, Robert V. O’Toole, (unknown), Anne‐Marie Maddox, David S. Alberts	3
16	A phase II trial of piroxantrone in adenocarcinoma of the pancreas 1993 ·Investigational New Drugs ·(unknown), Catherine M. Tangen, John S. Macdonald, Geoffrey R. Weiss, Robert Chapman, Alexander Hantel	8
17	Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck 1993 ·Investigational New Drugs ·Sarah A. Taylor, Jacqueline Benedetti, David Schuller, Stephen P. Richman, G. O. Broun, Alexander Hantel	2
18	Phase II trial of piroxantrone for advanced or metastatic soft tissue sarcomas 1993 ·Investigational New Drugs ·Mark M. Zalupski, Jacqueline Benedetti, Stanley P. Balcerzak, Laura F. Hutchins, Robert J. Belt, Alexander Hantel, J. Wendall Goodwin	8
19	Listeriosis in the setting of malignant disease. Changing issues in an unusual infection 1989 ·Cancer ·Alexander Hantel, James D. Dick, Judith E. Karp	16
20	Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study 1989 ·Investigational New Drugs ·Eric K. Rowinsky, Louise B. Grochow, Alexander Hantel, David S. Ettinger, (unknown), Ross C. Donehower	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact